Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...
Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...